Literature DB >> 26036195

Isolation and characterization of monoclonal antibodies specific for chondroitin sulfate E.

Ippei Watanabe1, Tomoya Hikita2, Haruka Mizuno2, Risa Sekita2, Akira Minami2, Ami Ishii2, Yuka Minamisawa3, Kiyoshi Suzuki3, Hiroshi Maeda3, Kazuya I P J Hidari4, Takashi Suzuki5.   

Abstract

Chondroitin sulfate E (CSE) is a polysaccharide containing mainly disaccharide units of D-glucuronic acid (GlcA) and 4,6-O-disulfated N-acetyl-D-galactosamine (GalNAc) residues (E-unit) in the amount of ∼ 60%. CSE is involved in many biological and pathological processes. In this study, we established new monoclonal antibodies, termed E-12C and E-18H, by using CSE that contained more than 70% of E-units as an immunogen. These antibodies recognized CSE but not other CSs isomers or dermatan sulfate (DS). We evaluated the reactivities of the antibodies to 6-O-sulfated CSA (6S-CSA) and DS (6S-DS) that possessed ∼ 60% of GalNAc (4S, 6S) moieties in their structures. Neither of the antibodies reacted with 6S-DS. The antibodies strictly distinguished the structural difference of GlcA and L-iduronic acid in the polysaccharide. Binding affinities of the antibodies were determined by a surface plasmon resonance assay using CSE and 6S-CSA. The binding affinities were strongly associated with the molecular weight of CSE and the E-unit content of 6S-CSA. Moreover, we demonstrated that the antibodies are applicable to histochemical analysis. In conclusion, the new anti-CSE monoclonal antibodies specifically recognize the E-unit of CSE. The antibodies will become useful tools for the investigation of the biological and pathological significance of CSE.
© The Author 2015. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  binding affinity; chondroitin sulfate E; glycosaminoglycan; monoclonal antibody; surface plasmon resonance

Mesh:

Substances:

Year:  2015        PMID: 26036195     DOI: 10.1093/glycob/cwv039

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  4 in total

1.  Hyaluronidase-4 is produced by mast cells and can cleave serglycin chondroitin sulfate chains into lower molecular weight forms.

Authors:  Brooke L Farrugia; Shuji Mizumoto; Megan S Lord; Robert L O'Grady; Rhiannon P Kuchel; Shuhei Yamada; John M Whitelock
Journal:  J Biol Chem       Date:  2019-06-07       Impact factor: 5.157

2.  Structure-function characterization of three human antibodies targeting the vaccinia virus adhesion molecule D8.

Authors:  Michael H Matho; Andrew Schlossman; Iuliia M Gilchuk; Greg Miller; Zbigniew Mikulski; Matthias Hupfer; Jing Wang; Aruna Bitra; Xiangzhi Meng; Yan Xiang; Tom Kaever; Tzanko Doukov; Klaus Ley; Shane Crotty; Bjoern Peters; Linda C Hsieh-Wilson; James E Crowe; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2017-11-09       Impact factor: 5.157

Review 3.  Nanotechnology and Glycosaminoglycans: Paving the Way Forward for Ovarian Cancer Intervention.

Authors:  Yasar Hoosen; Priyamvada Pradeep; Pradeep Kumar; Lisa C du Toit; Yahya E Choonara; Viness Pillay
Journal:  Int J Mol Sci       Date:  2018-03-04       Impact factor: 5.923

4.  Substrate specificity of Chondroitinase ABC I based on analyses of biochemical reactions and crystal structures in complex with disaccharides.

Authors:  Makoto Takashima; Ippei Watanabe; Akimasa Miyanaga; Tadashi Eguchi
Journal:  Glycobiology       Date:  2021-12-18       Impact factor: 4.313

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.